Product Description
The Haemophilus influenzae type B vaccine, often called Hib vaccine, is a vaccine used to prevent Haemophilus influenzae type b infection. In countries that include it as a routine vaccine, rates of severe Hib infections have decreased more than 90%.
Highly Effective Pediatric ImmunizationThe HIB Vaccine delivers comprehensive protection against serious Hib infections in young children through active immunization. Its high efficacy and strong safety profile make it a reliable choice for pediatric vaccination programs, especially in regions with a high burden of Hib disease. The vaccines liquid formulation and single-dose packaging ensure easy administration and minimized risk of contamination.
Safe Administration and StorageAdministered as a 0.5 ml intramuscular injection, the HIB Vaccine is easy for healthcare providers to handle. Proper storage at 2C to 8C maintains its potency, while the single-dose vial ensures accurate dosing. Strict adherence to storage guidelines preserves vaccine quality and effectiveness for up to 24 months.
FAQs of HIB Vaccine:
Q: How is the HIB Vaccine administered to children?
A: The HIB Vaccine is administered as a single 0.5 ml dose via intramuscular injection, typically in the thigh or upper arm of children, following recommended immunization schedules.
Q: What are the main benefits of using the HIB Vaccine?
A: The vaccine offers high efficacy in preventing severe Hib infections such as meningitis, pneumonia, and epiglottitis in children, supporting healthier childhood development and reducing related complications.
Q: When should children receive the HIB Vaccine?
A: The vaccine is generally recommended for children between 2 months and 5 years of age, with dosing schedules determined by local or national immunization programs.
Q: Where should the HIB Vaccine be stored before use?
A: The vaccine must be kept refrigerated between 2C and 8C and should never be frozen, as improper storage may compromise its effectiveness.
Q: What minor side effects might occur after HIB Vaccine administration?
A: Some children may experience mild reactions, such as redness or swelling at the injection site, or a low-grade fever, which generally resolve on their own.
Q: Who should not receive the HIB Vaccine?
A: Children with known hypersensitivity to any of the vaccines components should not be given the HIB Vaccine, and healthcare professionals should always review patient history before administration.
Q: What makes the HIB Vaccine suitable for broad distribution?
A: With WHO prequalification, high efficacy, and single-dose vials, the HIB Vaccine is ideal for wide distribution through dealers, suppliers, and healthcare facilities across India and globally.